Bionano Genomics (BNGO) vs Retractable Technologies (RVP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bionano Genomics (BNGO) has outperformed Retractable Technologies (RVP) over the past year, losing 26.3% versus a loss of 28.0%. Over five years, RVP leads with a -92.8% price change compared with -100.0% for BNGO. Retractable Technologies is the larger company by market cap ($19.9 million vs $17.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNGO | RVP |
|---|---|---|
| Share price | $1.46 | $0.6631 |
| Market cap | $17.14M | $19.85M |
| 1-day change | -0.34% | +0.17% |
| YTD return | -4.58% | -14.03% |
| 1-year return | -26.26% | -28.04% |
| 5-year return | -99.95% | -92.76% |
| EPS (TTM) | $-3.02 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.23 | $1.14 |
| 52-week low | $1.00 | $0.60 |
| Distance from 52-week high | -34.75% | -41.83% |
| Analyst consensus | none | — |
| Avg. price target upside | +243.64% | — |
| Average volume | 921.59K | 27.81K |
| Shares outstanding | 11.78M | 29.94M |
| Employees | 95 | 195 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Bionano Genomics in Industrials and Retractable Technologies in Health Care.
About Bionano Genomics
BNGO stock →Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Industrials · Biotechnology: Laboratory Analytical Instruments · 95 employees
About Retractable Technologies
RVP stock →Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Health Care · Medical/Dental Instruments · 195 employees
BNGO vs RVP FAQ
Which is bigger, Bionano Genomics or Retractable Technologies?
Retractable Technologies (RVP) is larger, with a market capitalization of $19.85M compared with $17.14M for Bionano Genomics (BNGO).
Which stock has performed better over the past year, BNGO or RVP?
BNGO returned -26.26% over the past 12 months, compared with -28.04% for RVP (price return, excluding dividends). Past performance does not predict future results.
Are Bionano Genomics and Retractable Technologies in the same industry?
No. Bionano Genomics is in the Industrials sector, while Retractable Technologies is in Health Care.